NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three and six ...
"Our Triple Down on Bronchiectasis marketing campaign is generating tremendous physician and patient awareness as we work to serve the nearly 800,000 diagnosed bronchiectasis patients who could ...
Strong operational execution results in thirteenth consecutive quarter of year-over-year revenue and net income growth NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (ELMD), a leader in ...
Net revenues increased 16.3% to a record $18.9 million in Q2 FY 2026, from $16.3 million in the second quarter of the prior fiscal year, led by an 18.4% increase in the core homecare market. Operating ...
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for ...
Electromed Inc. (ELMD) reported strong financial results for the second quarter of fiscal year 2026, surpassing earnings and revenue forecasts. The company posted an earnings per share (EPS) of $0.32, ...
Natural Language to SQL (NL2SQL) enables intuitive interactions with databases by transforming natural language queries into structured SQL statements. Despite recent advancements in enhancing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results